\n \nComposition?: \n \nCapsule 15 : Lansoprazole 15 mg. \n \nCapsule 30 : Lansoprazole 30 mg. \n \n  \n \nIndications?: \n \nbenign gastric ulcer, duodenal ulcer, NSAID-associated duodenal or gastric ulcer, peptic ulcer associated with H. pylori, Zollinger-Ellison syndrome, gastro-esophageal reflux disease and acid-related dyspepsia. \n \n  \n \nDosage & Administration?: \n \nBenign gastric ulcer : 30 mg daily for 8 weeks. Duodenal ulcer : 30 mg daily for 4 weeks. NSAID-associated duodenal or gastric ulcer : 15-30 mg once daily for 4 weeks. Further 4 weeks can be given if not fully healed. \n \nPeptic ulcer associated with H. Pylori (Triple therapy) \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Regimens	Dosage	Duration
Lansoprazole (Lansodin ?) \n \nClarithromycin (Claricin) \n \nAmoxicillin (Moxilin)	30 mg twice daily \n \n500 mg twice daily \n \n1 g twice daily	01 week
Lansoprazole (Lansodin ?) \n \nClarithromycin (Claricin) \n \nMetronidazole (Dirozyl)	30 mg twice daily \n \n500 mg twice daily \n \n400 mg twice daily	01 week
Lansoprazole (Lansodin ?) \n \nAmoxicillin (Moxilin) \n \nMetronidazole (Dirozyl)	30 mg twice daily \n \n1 g twice daily \n \n400 mg twice daily	01 week

\nZollinger-Ellison syndrome : Initially 60 mg once daily adjusted according to response. Daily doses of 120 mg or more given in two divided doses. \n \nGastro-esophageal reflux disease : 30 mg daily in the morning for 4 weeks. Further 4 weeks can be given if not fully healed. Maintenance dose : 15 - 30 mg daily. \n \nAcid-related dyspepsia : 15 - 30 mg daily in the morning for 2 - 4 weeks. \n \n